DAM
ICPT

DLD Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

DLD Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,000
Closed -$138K – 230
2022
Q2 		$138K Buy
+10,000
New +$160K 0.01% 206
2022
Q1 		– Sell
-250,000
Closed -$4.07M – 239
2021
Q4 		$4.07M Buy
250,000
+24,800
+11% +$418K 0.22% 64
2021
Q3 		$3.35M Buy
+225,200
New +$3.6M 0.24% 59
2020
Q3 		– Sell
-65,000
Closed -$3.11M – 92
2020
Q2 		$3.11M Buy
65,000
+1,800
+3% +$139K 0.14% 48
2020
Q1 		$3.97M Buy
+63,200
New +$5.68M 0.25% 45
2019
Q3 		– Sell
-15,000
Closed -$1.19M – 92
2019
Q2 		$1.19M Sell
15,000
-1,434,900
-99% -$128M 0.05% 69
2019
Q1 		$162M Buy
1,449,900
+615,300
+74% +$67.2M 5.97% 5
2018
Q4 		$84.1M Buy
834,600
+341,600
+69% +$35.4M 5.77% 6
2018
Q3 		$62.3M Buy
493,000
+364,000
+282% +$38.5M 3.08% 7
2018
Q2 		$10.8M Buy
+129,000
New +$9.45M 0.82% 31

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return